Latest Breaking News On - Sphere bio - Page 1 : comparemela.com

BlueSphere Bio to Present Corporate Update and Participate in a Panel Discussion at the 2024 BIO International Convention

BlueSphere Bio to Present Corporate Update and Participate in a Panel Discussion at the 2024 BIO International Convention
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San diego convention centerUnited statesSan diegoAngus liuKim jaffeBluesphere bioAndrew mielachKeir loiaconoLifesci communicationsPanel discussionHead of business development strategyWhile the companyInternational conventionCompany contactSphere bioPresent corporate update

BlueSphere Bio to Present at the Next Generation CAR & T Cell Therapies Conference

BlueSphere Bio to Present at the Next Generation CAR & T Cell Therapies Conference
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

San diego convention centerUnited statesSan diegoBluesphere bioAndrew mielachRobert keefeKim jaffeWhile the companyHead of business development strategyLifesci communicationsCompany contactChief development officerNext generationCell therapies conferenceInvestigational new drug applicationPowerful platform

BlueSphere Bio Data to be Presented at the 2022 Joint ASTCT

PITTSBURGH, May 25, 2022 (GLOBE NEWSWIRE) BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a powerful TCR discovery platform.

Bluesphere bioSawa itoAndrew mielachKim jaffeBusiness development operationsCompany contactUniversity of pittsburgh school medicineHigh throughput cloning reveals diverse propertiesLifesci communicationsDepartment of immunologyHillman cancer centerDivision of hematologySphere bioTranslational scientificCancer centerAssistant professor

BlueSphere Bio Data to be Presented at the 2022 American

PITTSBURGH, March 15, 2022 (GLOBE NEWSWIRE) BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a revolutionary TCR discovery.

United statesBluesphere bioSawa itoAndrew mielachKim jaffeBusiness development operationsCompany contactUniversity of pittsburgh school medicineClinical research excluding trialsAmerican association for cancer researchLifesci communicationsHillman cancer centerDivision of hematologySphere bioCancer centerAssistant professor

BlueSphere Bio to Present at the BIO CEO & Investor

PITTSBURGH, Feb. 08, 2022 (GLOBE NEWSWIRE) BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a revolutionary TCR discovery.

New yorkUnited statesBluesphere bioDavid apelianAndrew mielachMarriott marquisKim jaffeInvestor forumBusiness development operationsLifesci communicationsCompany contactSphere bioNew york marriott marquisBusiness development